{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T18:06:13Z","timestamp":1778090773408,"version":"3.51.4"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.breast.2020.11.019","type":"journal-article","created":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T05:30:35Z","timestamp":1606541435000},"page":"328-330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Complete response of leptomeningeal carcinomatosis secondary to breast cancer"],"prefix":"10.1016","volume":"54","author":[{"given":"Idriss","family":"Troussier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Canova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8972-2832","authenticated-orcid":false,"given":"Guillaume","family":"Klausner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2020.11.019_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.critrevonc.2019.01.020","article-title":"Leptomeningeal carcinomatosis in patients with breast cancer","volume":"135","author":"Franzoi","year":"2019","journal-title":"Crit Rev Oncol Hematol. 1 mars"},{"issue":"15_suppl","key":"10.1016\/j.breast.2020.11.019_bib2","article-title":"A\u00a0phase II study of abemaciclib in patients (pts) with brain metastases (BM) secondary to HR+, HER2- metastatic breast cancer (MBC)","volume":"37","author":"Anders","year":"2019","journal-title":"J\u00a0Clin Oncol. 20 mai"},{"issue":"6","key":"10.1016\/j.breast.2020.11.019_bib3","article-title":"Leptomeningeal metastases","volume":"2","author":"Corbin","year":"2016","journal-title":"JAMA Oncol. 1 juin"},{"issue":"9","key":"10.1016\/j.breast.2020.11.019_bib4","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1124\/dmd.114.062745","article-title":"Brain exposure of two selective dual CDK4 and CDK6 inhibitors and the antitumor activity of CDK4 and CDK6 inhibition in combination with temozolomide in an intracranial glioblastoma xenograft","volume":"43","author":"Raub","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"59","key":"10.1016\/j.breast.2020.11.019_bib5","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.18632\/oncotarget.27238","article-title":"Central nervous system-specific efficacy of CDK4\/6 inhibitors in randomized controlled trials for metastatic breast cancer","volume":"10","author":"Nguyen","year":"2019","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.breast.2020.11.019_bib6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1200\/JCO.19.02767","article-title":"Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG Oncology CC001","volume":"38","author":"Brown","year":"2020","journal-title":"J\u00a0Clin Oncol. 14 f\u00e9vr"},{"issue":"3","key":"10.1016\/j.breast.2020.11.019_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11060-019-03260-6","article-title":"CDK 4\/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases","volume":"144","author":"Figura","year":"2019","journal-title":"J\u00a0Neurooncol. sept"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977620302253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977620302253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:44:23Z","timestamp":1760777063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977620302253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":7,"alternative-id":["S0960977620302253"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2020.11.019","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complete response of leptomeningeal carcinomatosis secondary to breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2020.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}